[P02BB01, trichlorfon, Metrifonate may increase the neuromuscular blocking activities of Doxacurium.]
[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01GA01, streptomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Streptomycin.]
[M03AB01, succinylcholine, Succinylcholine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CG01, sulbactam, Doxacurium may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01CA16, sulbenicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Sulbenicillin.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AL01, sulpiride, Doxacurium may increase the anticholinergic activities of Sulpiride.]
[N03AX03, sulthiame, Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06DA01, tacrine, Tacrine may increase the neuromuscular blocking activities of Doxacurium.]
[J01CA15, talampicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Talampicillin.]
[N05CD07, temazepam, Temazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R03CC03, terbutaline, Terbutaline may increase the neuromuscular blocking activities of Doxacurium.]
[B01AE07, dabigatran etexilate, Doxacurium may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01HA03, tetracaine, Tetracaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S03AA02, tetracycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AE05, lurasidone, Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04BC07, apomorphine, Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L04AX02, thalidomide, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L01AC01, thiotepa, Thiotepa may increase the neuromuscular blocking activities of Doxacurium.]
[N05CA19, thiopental, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AB08, thioproperazine, Thioproperazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AC02, thioridazine, Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AF04, thiothixene, Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[B02AB01, aprotinin, Aprotinin may increase the neuromuscular blocking activities of Doxacurium.]
[G04BE06, moxisylyte, Doxacurium may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Tiapride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01CA13, ticarcillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Ticarcillin.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Tilidine.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[P01AB02, tinidazole, The therapeutic efficacy of Doxacurium can be increased when used in combination with Tinidazole.]
[S01AA12, tobramycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Tobramycin.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M03BX04, tolperisone, Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AX02, tramadol, The risk or severity of CNS depression can be increased when Doxacurium is combined with Tramadol.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AX05, trazodone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Trazodone.]
[S01BA05, triamcinolone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Triamcinolone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, Triazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB12, mepenzolate, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[S01EB04, demecarium, Demecarium may increase the neuromuscular blocking activities of Doxacurium.]
[A16AX12, trientine, Doxacurium may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AD02, trifluperidol, Trifluperidol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AA05, triflupromazine, Triflupromazine may increase the neuromuscular blocking activities of Doxacurium.]
[D07AC02, fluclorolone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluclorolone.]
[N04AA01, trihexyphenidyl, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Mometasone.]
[A03AA05, trimebutine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, Alimemazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AC02, trimethadione, Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Trimethaphan is combined with Doxacurium.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AA06, trimipramine, Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AX07, triprolidine, Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03BB01, butylscopolamine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01FA06, tropicamide, The risk or severity of adverse effects can be increased when Tropicamide is combined with Doxacurium.]
[N06AX02, tryptophan, Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M03AA02, tubocurarine, Tubocurarine may increase the neuromuscular blocking activities of Doxacurium.]
[R03DX07, roflumilast, Doxacurium may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Doxacurium may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[S01AA05, tyrothricin, Tyrothricin may increase the neuromuscular blocking activities of Doxacurium.]
[R02AA14, oxyquinoline, Doxacurium may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[S01AA28, vancomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Vancomycin.]
[N03AX21, ezogabine, Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[B01AF01, rivaroxaban, Doxacurium may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, Verapamil may increase the neuromuscular blocking activities of Doxacurium.]
[N06AX09, viloxazine, Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[B01AA03, warfarin, Doxacurium may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[N01AX15, xenon, Xenon may increase the neuromuscular blocking activities of Doxacurium.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AF05, zuclopenthixol, Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AX14, levetiracetam, Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[B06AC02, icatibant, Doxacurium may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Doxacurium may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Doxacurium may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[J01DH04, doripenem, Doxacurium may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[M03AC04, atracurium, Atracurium may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01FA01, atropine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H02AB11, prednylidene, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Prednylidene.]
[B03XA04, peginesatide, Doxacurium may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L04AX01, azathioprine, The therapeutic efficacy of Doxacurium can be decreased when used in combination with Azathioprine.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CA09, azlocillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Azlocillin.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M03BX01, baclofen, The therapeutic efficacy of Doxacurium can be increased when used in combination with Baclofen.]
[A08AA11, lorcaserin, Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G04BD12, mirabegron, The risk or severity of urinary retention can be increased when Doxacurium is combined with Mirabegron.]
[L02BB04, enzalutamide, Doxacurium may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Doxacurium.]
[A02AA05, magnesium silicate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium silicate.]
[H02AA01, aldosterone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Aldosterone.]
[N05CA04, barbital, Barbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01AA01, acetyldigitoxin, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Acetyldigitoxin.]
[D02BA02, octinoxate, Doxacurium may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04BD02, rasagiline, Rasagiline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA13, lercanidipine, Lercanidipine may increase the neuromuscular blocking activities of Doxacurium.]
[A03FA09, mosapride, Mosapride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06DA02, donepezil, The therapeutic efficacy of Doxacurium can be decreased when used in combination with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02CC03, zolmitriptan, Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AC06, thonzylamine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[V09IX04, fluorodeoxyglucose F18, Doxacurium may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V08CA11, gadofosveset, Doxacurium may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Doxacurium may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C04AX11, bencyclane, Bencyclane may increase the neuromuscular blocking activities of Doxacurium.]
[A10BH04, alogliptin, Doxacurium may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Doxacurium may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AD07, benperidol, Benperidol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[A12CC09, magnesium orotate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium orotate.]
[A06AX06, tegaserod, The therapeutic efficacy of Tegaserod can be decreased when used in combination with Doxacurium.]
[R02AD01, benzocaine, Benzocaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BX05, pramlintide, The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Doxacurium.]
[L03AA12, ancestim, Doxacurium may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02CC02, naratriptan, Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A12CC05, magnesium aspartate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium aspartate.]
[N04AC01, benztropine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01EE01, trametinib, Doxacurium may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V09AX05, florbetapir F-18, Doxacurium may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, The risk or severity of adverse effects can be increased when Doxacurium is combined with Levomilnacipran.]
[C08EA02, bepridil, Bepridil may increase the neuromuscular blocking activities of Doxacurium.]
[A10BJ03, lixisenatide, Doxacurium may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Doxacurium may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AF04, eslicarbazepine, Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J05AP08, sofosbuvir, Doxacurium may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Doxacurium may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L04AA32, apremilast, Doxacurium may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Doxacurium may decrease the excretion rate of Formestane which could result in a higher serum level.]
[A16AA06, betaine, Betaine may increase the neuromuscular blocking activities of Doxacurium.]
[S03BA03, betamethasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Betamethasone.]
[V03AB34, fomepizole, Doxacurium may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[A03BA03, hyoscyamine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[N01AX05, alfaxalone, Alfaxalone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Doxacurium is combined with Glycopyrronium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05CM19, suvorexant, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[S01AA15, dihydrostreptomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Dihydrostreptomycin.]
[N05AA04, acepromazine, Acepromazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V04CX03, methacholine, Doxacurium may decrease effectiveness of Methacholine as a diagnostic agent.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Doxacurium.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Doxacurium is combined with Naloxegol.]
[N04AA02, biperiden, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Doxacurium.]
[S03AA06, gentamicin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Gentamicin.]
[B01AF03, edoxaban, Doxacurium may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A03AA09, difemerine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Doxacurium is combined with Eluxadoline.]
[N05AX16, brexpiprazole, Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G02CX02, flibanserin, Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Doxacurium.]
[N05AX15, cariprazine, Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AB07, acetophenazine, Acetophenazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V03AB37, idarucizumab, Doxacurium may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Doxacurium.]
[L01XG03, ixazomib, Doxacurium may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Doxacurium may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[N05CA05, aprobarbital, Aprobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BA08, bromazepam, Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04BC01, bromocriptine, Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A02AD05, aluminum magnesium silicate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium Aluminum Silicate.]
[A03AX08, alverine, Alverine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AB01, brompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA19, amineptin, Amineptine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA01, amlodipine, Amlodipine may increase the neuromuscular blocking activities of Doxacurium.]
[N06BX11, aniracetam, Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03CA02, bumetanide, Bumetanide may decrease the neuromuscular blocking activities of Doxacurium.]
[N01BB01, bupivacaine, Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N07BC01, buprenorphine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, Buspirone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L01XX27, arsenic trioxide, Doxacurium may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[N06DA03, rivastigmine, Rivastigmine may increase the neuromuscular blocking activities of Doxacurium.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Doxacurium is combined with Butorphanol.]
[S01GX07, azelastine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[J01CE04, azidocillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Azidocillin.]
[J01CA06, bacampicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Bacampicillin.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Doxacurium.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R03CC12, bambuterol, Bambuterol may increase the neuromuscular blocking activities of Doxacurium.]
[A06AH05, naldemedine, Doxacurium may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Doxacurium may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, Beclamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01HA02, benoxinate, Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R05DB01, benzonatate, The serum concentration of Doxacurium can be increased when it is combined with Benzonatate.]
[P01CA02, benznidazole, Doxacurium may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N07XX13, valbenazine, Doxacurium may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01MA23, delafloxacin, Doxacurium may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J05AG03, efavirenz, Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N04AA11, bornaprine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CD09, brotizolam, Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Budesonide.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05CA03, butobarbital, Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA15, butriptyline, Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01AA02, acetyldigoxins, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Acetyldigoxin.]
[N01BX04, capsaicin, Capsaicin may increase the neuromuscular blocking activities of Doxacurium.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA08, butylvinal, Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AX18, acrivastine, Doxacurium may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Doxacurium.]
[L02BB05, apalutamide, Doxacurium may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Doxacurium may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Doxacurium.]
[A03AA03, camylofine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[J01CA03, carbenicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Carbenicillin.]
[R06AA08, carbinoxamine, Carbinoxamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C07AG02, carvedilol, Carvedilol may increase the neuromuscular blocking activities of Doxacurium.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Doxacurium.]
[L04AA37, baricitinib, Doxacurium may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01GB14, plazomicin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Plazomicin.]
[A16AX14, migalastat, Doxacurium may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01GX12, cetirizine, Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CM04, carbromal, Carbromal may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01BA04, chloroprocaine, Chloroprocaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[D08AE05, chloroxylenol, Doxacurium may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Doxacurium.]
[R03BB08, revefenacin, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Doxacurium.]
[B01AC23, cilostazol, Doxacurium may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[A03FA08, cinitapride, Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Esketamine.]
[N06BA14, solriamfetol, Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AX29, brexanolone, Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BA09, clobazam, Clobazam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01AA11, clomocycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Clomocycline.]
[H02AB14, cloprednol, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Cloprednol.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Doxacurium.]
[N05BA22, cloxazolam, Cloxazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[H02AB17, cortivazol, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Cortivazol.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CF03, methicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Meticillin.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AA06, cyamemazine, Cyamemazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Doxacurium.]
[N07XX11, pitolisant, Doxacurium may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Doxacurium.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H02AB13, deflazacort, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Deflazacort.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Doxacurium.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M09AX08, golodirsen, Doxacurium may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01XA12, dexpanthenol, Doxacurium may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Dezocine.]
[N05CM21, lemborexant, Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AD10, lumateperone, Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02CC07, frovatriptan, Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CC04, dichloralphenazone, Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R02AA03, dichlorobenzyl alcohol, Doxacurium may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Doxacurium may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[A07DA04, difenoxin, Difenoxin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Dihydrocodeine.]
[N02CC06, eletriptan, Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C08CA16, clevidipine, Clevidipine may increase the neuromuscular blocking activities of Doxacurium.]
[N03AG02, dipropylacetamide, Valpromide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BA02, chlordiazepoxide, Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03AA08, dihexyverine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[D07XB03, fluprednidene, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluprednidene.]
[G04BD09, trospium, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[V08CA05, mangafodipir, Doxacurium may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05CM02, chlormethiazole, Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M03BB02, chlormezanone, Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R02AD04, dyclonine, Dyclonine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA17, levamlodipine, Levamlodipine may increase the neuromuscular blocking activities of Doxacurium.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Doxacurium is combined with Remimazolam.]
[N07XX04, sodium oxybate, Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Doxacurium is combined with Oliceridine.]
[P01BA01, chloroquine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Chloroquine.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the neuromuscular blocking activities of Doxacurium.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AF03, chlorprothixene, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BX03, etifoxine, Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06BX18, vinpocetine, Vinpocetine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BA18, ethyl loflazepate, Ethyl loflazepate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AX25, chondroitin sulfates, Doxacurium may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[M03BA05, febarbamate, Febarbamate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AX10, felbamate, Felbamate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R03BA03, flunisolide, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluocinolone acetonide.]
[N02BG07, flupirtine, Doxacurium may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02BF01, gabapentin, Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N07CA02, cinnarizine, Cinnarizine may increase the neuromuscular blocking activities of Doxacurium.]
[S03AA07, ciprofloxacin, Ciprofloxacin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01XA01, cisplatin, Doxacurium may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of adverse effects can be increased when Doxacurium is combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AA04, clemastine, Clemastine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01FF01, clindamycin, The risk or severity of neuromuscular blockade can be increased when Clindamycin is combined with Doxacurium.]
[N06AX25, St. John's wort extract, St. John's Wort may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Doxacurium.]
[N01BB10, levobupivacaine, Levobupivacaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA04, clomipramine, Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AE01, clonazepam, Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Doxacurium.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH06, clothiapine, Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BA21, clotiazepam, Clotiazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A04AA01, ondansetron, Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A04AA02, granisetron, Granisetron may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01CF02, cloxacillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Cloxacillin.]
[N05AH02, clozapine, Clozapine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01GB12, arbekacin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Arbekacin.]
[N05BA13, halazepam, Halazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S02DA02, cocaine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Doxacurium may increase the sedative activities of Metyrosine.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Codeine.]
[J01CA18, hetacillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Hetacillin.]
[M03AC05, hexafluorenium, Hexafluronium may increase the neuromuscular blocking activities of Doxacurium.]
[M04AC01, colchicine, Doxacurium may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[A03AB10, hexocyclium, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[S01FA05, homatropine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Homatropine.]
[J01XB01, colistin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Colistin.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A04AA03, tropisetron, Tropisetron may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C04AX28, ifenprodil, Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R03BA08, ciclesonide, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Ciclesonide.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R06AX27, desloratadine, Desloratadine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J05AB14, valganciclovir, Doxacurium may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Doxacurium may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Doxacurium may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Doxacurium may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Doxacurium may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Doxacurium may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H01AX01, pegvisomant, Pegvisomant may increase the neuromuscular blocking activities of Doxacurium.]
[C01AA06, lanatoside C, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Lanatoside C.]
[N02CC05, almotriptan, Almotriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05BA10, ketazolam, Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C08CA09, lacidipine, Lacidipine may increase the neuromuscular blocking activities of Doxacurium.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Doxacurium.]
[N03AX09, lamotrigine, Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01GX02, levocabastine, Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01BA03, cortisone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Lofexidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R06AX13, loratadine, Doxacurium may increase the anticholinergic activities of Loratadine.]
[N05CD06, lormetazepam, Lormetazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium carbonate.]
[B05XA10, magnesium phosphate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium phosphate.]
[C08CA11, manidipine, Manidipine may increase the neuromuscular blocking activities of Doxacurium.]
[A03AA04, mebeverine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, Medifoxamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[H02AB15, meprednisone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Meprednisone.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CA14, methampicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Metampicillin.]
[N04AA03, methixene, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, Cyclandelate may increase the neuromuscular blocking activities of Doxacurium.]
[R06AE03, cyclizine, Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CA10, cyclobarbital, Cyclobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Melperone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[S01FA04, cyclopentolate, The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Doxacurium.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AX07, minaprine, Minaprine may increase the neuromuscular blocking activities of Doxacurium.]
[S01XA18, cyclosporine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Cyclosporine.]
[N06AG02, moclobemide, Moclobemide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AX02, cyproheptadine, Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M03CA01, dantrolene, The therapeutic efficacy of Doxacurium can be increased when used in combination with Dantrolene.]
[N06BX04, deanol, Deanol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N07BB05, nalmefene, Doxacurium may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[J01AA01, demeclocycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Demeclocycline.]
[N05BA16, nordazepam, Nordazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AX06, nefazodone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Nefazodone.]
[N05CM16, niaprazine, Niaprazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01DX16, nicorandil, Doxacurium may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AG06, tiagabine, Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M03AC11, cisatracurium, Cisatracurium may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Normethadone.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AB10, escitalopram, The risk or severity of adverse effects can be increased when Doxacurium is combined with Escitalopram.]
[G04BD08, solifenacin, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AA01, desipramine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Desipramine.]
[C01AA07, deslanoside, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Deslanoside.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[D07XC02, desoximetasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Desoximetasone.]
[H02AA03, desoxycorticosterone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Desoxycortone.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AF02, oxcarbazepine, Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S03BA01, dexamethasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Dexamethasone.]
[N06BX07, oxiracetam, Oxiracetam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04AA08, dexetimide, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A03AA01, oxyphencyclimine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R05DA09, dextromethorphan, Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AC01, paramethadione, Paramethadione may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Doxacurium is combined with Dextromoramide.]
[N06AB05, paroxetine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Paroxetine.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Doxacurium is combined with Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Doxacurium may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Doxacurium may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AX07, phenacemide, Phenacemide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01CE05, phenethicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Pheneticillin.]
[N03AD02, phensuximide, Phensuximide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA08, dibenzepin, Dibenzepin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S02DA04, dibucaine, Cinchocaine may increase the neuromuscular blocking activities of Doxacurium.]
[R05DA08, pholcodine, Doxacurium may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CF01, dicloxacillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Dicloxacillin.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A03AA07, dicyclomine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A03AX04, pinaverium, Pinaverium may increase the neuromuscular blocking activities of Doxacurium.]
[N05AD05, pipamperone, Pipamperone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03AB14, pipenzolate, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[C03CA03, piretanide, Piretanide may decrease the neuromuscular blocking activities of Doxacurium.]
[P02CB02, diethylcarbamazine, Diethylcarbamazine may increase the neuromuscular blocking activities of Doxacurium.]
[A08AA03, diethylpropion, Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA03, isradipine, Isradipine may increase the neuromuscular blocking activities of Doxacurium.]
[D07XC04, diflucortolone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Difluocortolone.]
[A03AB11, poldine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01AA04, digitoxin, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Digitoxin.]
[C01AA05, digoxin, Doxacurium may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Hydromorphone.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Doxacurium may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[D04AB07, pramoxine, Pramocaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08DB01, diltiazem, Diltiazem may increase the neuromuscular blocking activities of Doxacurium.]
[R06AA11, dimenhydrinate, Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V03AB09, dimercaprol, Doxacurium may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M03BX03, pridinol, Pridinol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AB03, dimethindene, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AG05, progabide, Progabide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01CE03, propicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Propicillin.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R06AA02, diphenhydramine, Diphenhydramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Doxacurium is combined with Diphenoxylate.]
[N05CD10, quazepam, Quazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA23, quinupramine, Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03FA02, cisapride, Cisapride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AL04, remoxipride, Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01AX06, resorcinol, Doxacurium may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[N07AA03, distigmine, Distigmine may increase the neuromuscular blocking activities of Doxacurium.]
[N07XX02, riluzole, Riluzole may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AX08, risperidone, Risperidone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AE09, levocetirizine, Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01BB09, ropivacaine, Ropivacaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of adverse effects can be increased when Ketorolac is combined with Doxacurium.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A03FA03, domperidone, The therapeutic efficacy of Domperidone can be decreased when used in combination with Doxacurium.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AA16, dothiepin, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Dosulepin.]
[N06AA12, doxepin, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Doxepin.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Doxacurium.]
[J01AA02, doxycycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Doxycycline.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AB06, sertraline, The risk or severity of adverse effects can be increased when Doxacurium is combined with Sertraline.]
[N01AB08, sevoflurane, Sevoflurane may increase the neuromuscular blocking activities of Doxacurium.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Sibutramine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Doxacurium.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Doxacurium.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AL02, sultopride, Sultopride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02CC01, sumatriptan, Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V04CX07, edrophonium, Edrophonium may increase the neuromuscular blocking activities of Doxacurium.]
[H01AA01, corticotropin, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Corticotropin.]
[J01CA17, temocillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Temocillin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[G04BD05, terodiline, Terodiline may increase the neuromuscular blocking activities of Doxacurium.]
[M03BX07, tetrazepam, Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M03BX05, thiocolchicoside, Thiocolchicoside may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AB05, thiopropazate, Thiopropazate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G04BD01, emepronium, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, Tianeptine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BA23, tofisopam, Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AX11, topiramate, The risk or severity of hyperthermia and oligohydrosis can be increased when Doxacurium is combined with Topiramate.]
[C03CA04, torsemide, Torasemide may decrease the neuromuscular blocking activities of Doxacurium.]
[J01AA12, tigecycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Tigecycline.]
[N05CD11, triazulenone, Loprazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CM07, triclofos, Triclofos may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03AB08, tridihexethyl, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[H02CA01, trilostane, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Trilostane.]
[R06AA10, trimethobenzamide, Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04AA12, tropatepine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Doxacurium.]
[C02CA06, urapidil, Urapidil may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AL06, veralipride, Veralipride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01FB02, ephedrine, The serum concentration of Ephedrine can be increased when it is combined with Doxacurium.]
[S01GX10, epinastine, Epinastine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AX16, venlafaxine, Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01GA03, xylometazoline, Xylometazoline may increase the neuromuscular blocking activities of Doxacurium.]
[C08CA12, mepirodipine, Barnidipine may increase the neuromuscular blocking activities of Doxacurium.]
[N05CF02, zolpidem, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CF01, zopiclone, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AX11, zotepine, Zotepine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01BG01, moricizine, Moricizine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G02AB03, ergonovine, Ergometrine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02CA02, ergotamine, Ergotamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L03AX05, pidotimod, Doxacurium may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Estazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluticasone.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05CM08, ethchlorvynol, Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N04AA05, profenamine, Profenamine may increase the neuromuscular blocking activities of Doxacurium.]
[N03AD01, ethosuximide, Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AB01, ethotoin, Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Ethylmorphine.]
[N01AX07, etomidate, Etomidate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AE03, sertindole, Sertindole may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L04AD02, tacrolimus, Tacrolimus may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A02BA04, nizatidine, Nizatidine may increase the neuromuscular blocking activities of Doxacurium.]
[R06AX12, terfenadine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[P01AX07, trimetrexate, Doxacurium may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AB08, fluvoxamine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Fluvoxamine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Doxacurium may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Doxacurium may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C08CA02, felodipine, Felodipine may increase the neuromuscular blocking activities of Doxacurium.]
[C08EA01, fendiline, Fendiline may increase the neuromuscular blocking activities of Doxacurium.]
[N03AX26, fenfluramine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Doxacurium is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Doxacurium is combined with Fentanyl.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[G04BD02, flavoxate, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CF05, floxacillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Flucloxacillin.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H02AA02, fludrocortisone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fludrocortisone.]
[V03AB25, flumazenil, Doxacurium may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07XB01, flumethasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Flumethasone.]
[N07CA03, flunarizine, Flunarizine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CD03, flunitrazepam, Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[D07AC08, fluocinonide, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluocinonide.]
[N06AA14, melitracen, Melitracen may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[H02AB03, fluocortolone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluocortolone.]
[V03AZ01, ethanol, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01CB05, fluorometholone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Fluorometholone.]
[N06AB03, fluoxetine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Flupentixol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AB02, fluphenazine, Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CD01, flurazepam, Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AG01, fluspirilene, Fluspirilene may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01AA07, framycetin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Framycetin.]
[L01BC03, tegafur, Doxacurium may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[M03AA01, alcuronium, Alcuronium may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G01AX06, furazolidone, Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03CA01, furosemide, Furosemide may decrease the neuromuscular blocking activities of Doxacurium.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Doxacurium is combined with Eszopiclone.]
[N05AL05, amisulpride, Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06DA04, galantamine, Galantamine may increase the neuromuscular blocking activities of Doxacurium.]
[M03AC02, gallamine, Gallamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08DA02, gallopamil, Gallopamil may increase the neuromuscular blocking activities of Doxacurium.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AA04, barbexaclone, Barbexaclone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AX08, bifemelane, Bifemelane may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C10AB04, gemfibrozil, Doxacurium may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Doxacurium may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[N04BC06, cabergoline, Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AD03, methsuximide, Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Doxacurium is combined with Alfentanil.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[H04AA01, glucagon, Doxacurium may increase the gastrointestinal motility reducing activities of Glucagon.]
[N05CM18, dexmedetomidine, Dexmedetomidine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CE01, glutethimide, Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Doxacurium.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M01CB04, aurothioglucose, Doxacurium may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Doxacurium may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01EX01, guanethidine, Doxacurium may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Doxacurium.]
[N01AB01, halothane, Halothane may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AH04, quetiapine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N06BX13, idebenone, Doxacurium may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[N02CX03, iprazochrome, Iprazochrome may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L01CE02, irinotecan, The serum concentration of Doxacurium can be increased when it is combined with Irinotecan.]
[N05CA21, allobarbital, Allobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium citrate.]
[A12CC03, magnesium gluconate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium gluconate.]
[G03DC01, allylestrenol, Doxacurium may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Doxacurium.]
[N05CA16, hexobarbital, Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA10, nilvadipine, Nilvadipine may increase the neuromuscular blocking activities of Doxacurium.]
[M02AA26, nimesulide, Nimesulide may increase the neuromuscular blocking activities of Doxacurium.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C02DB02, hydralazine, Doxacurium may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Doxacurium can be increased when used in combination with Hydrochlorothiazide.]
[R05DA03, hydrocodone, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Doxacurium may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[G04BD06, propiverine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[N05AX07, prothipendyl, Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[B05AA07, hetastarch, Doxacurium may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[B05XA08, sodium acetate, Doxacurium may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Doxacurium.]
[L01AA06, ifosfamide, Doxacurium may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Doxacurium is combined with Sufentanil.]
[N06AA02, imipramine, Imipramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R01AD07, tixocortol, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Tixocortol.]
[M03BX02, tizanidine, Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A11HA07, inositol, Doxacurium may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The risk or severity of adverse effects can be increased when Doxacurium is combined with Milnacipran.]
[A03AA30, piperidolate, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[S01XA28, varenicline, Doxacurium may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, Articaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BH01, sitagliptin, Doxacurium may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CH02, ramelteon, Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AE01, buclizine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C07AA01, alprenolol, Alprenolol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Doxacurium may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[N06AA13, iprindole, Iprindole may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AF05, iproniazid, Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AA07, chlorproethazine, Chlorproethazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01AB06, isoflurane, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01EB07, isoflurophate, Isoflurophate may increase the neuromuscular blocking activities of Doxacurium.]
[N04BX02, entacapone, Entacapone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J04AC01, isoniazid, Isoniazid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J05AX05, inosine pranobex, Doxacurium may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, Isoprenaline may increase the neuromuscular blocking activities of Doxacurium.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AX18, reboxetine, Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01AA24, kanamycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Kanamycin.]
[N01AX03, ketamine, Ketamine may increase the neuromuscular blocking activities of Doxacurium.]
[C02KD01, ketanserin, Ketanserin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[B01AC22, prasugrel, Doxacurium may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[J02AB02, ketoconazole, The therapeutic efficacy of Doxacurium can be increased when used in combination with Ketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N04BC09, rotigotine, Doxacurium may increase the sedative activities of Rotigotine.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Doxacurium.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Doxacurium.]
[N07AA30, ambenonium, Ambenonium may increase the neuromuscular blocking activities of Doxacurium.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Doxacurium.]
[N03AX18, lacosamide, Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03CC01, ethacrynic acid, The therapeutic efficacy of Doxacurium can be increased when used in combination with Etacrynic acid.]
[J01CA11, amdinocillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Amdinocillin.]
[J01CA08, amdinocillin pivoxil, The therapeutic efficacy of Doxacurium can be increased when used in combination with Pivmecillinam.]
[N04BA01, levodopa, The absorption of Levodopa can be decreased when combined with Doxacurium.]
[S02DA01, lidocaine, Lidocaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08EX01, lidoflazine, Lidoflazine may increase the neuromuscular blocking activities of Doxacurium.]
[J01FF02, lincomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Lincomycin.]
[S01AA21, amikacin, Doxacurium may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, Lisuride may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA07, lofepramine, Lofepramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A07DA03, loperamide, Loperamide may increase the neuromuscular blocking activities of Doxacurium.]
[N05BA06, lorazepam, Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AH01, loxapine, Loxapine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01AA04, lymecycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Lymecycline.]
[B05XA11, magnesium chloride, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium chloride.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium hydroxide.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium oxide.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Doxacurium can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, Doxacurium may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A08AA05, mazindol, Mazindol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C02BB01, mecamylamine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Mecamylamine.]
[L01AA05, mechlorethamine, Mechlorethamine may increase the neuromuscular blocking activities of Doxacurium.]
[R06AE05, meclizine, Meclizine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05BA03, medazepam, Medazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01AA08, medigoxin, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Metildigoxin.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Doxacurium.]
[P01BC02, mefloquine, Mefloquine may increase the neuromuscular blocking activities of Doxacurium.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, Melatonin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06DX01, memantine, Memantine may increase the neuromuscular blocking activities of Doxacurium.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Meperidine.]
[N03AB04, mephenytoin, Mephenytoin may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01BB03, mepivacaine, Mepivacaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BC01, meprobamate, Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Doxacurium is combined with Meptazinol.]
[G04BX16, tiopronin, Doxacurium may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, Mesoridazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AX13, paliperidone, Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A04AA04, dolasetron, Dolasetron may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01AA05, methacycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Metacycline.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Doxacurium.]
[N06BA03, methamphetamine, Metamfetamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03AB07, methantheline, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CM01, methaqualone, Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AA30, metharbital, Metharbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, Metergoline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L01BA04, pemetrexed, Doxacurium may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CA15, methohexital, Methohexital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02BG08, ziconotide, Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L04AX03, methotrexate, Methotrexate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AA02, methotrimeprazine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N02BG09, methoxyflurane, Methoxyflurane may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Doxacurium.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[V04CG05, methylene blue, Methylene blue may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[H02AB04, methylprednisolone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Methylprednisolone.]
[D07AC14, methylprednisolone aceponate, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Methylprednisolone aceponate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Doxacurium.]
[G03EK01, methyltestosterone, Doxacurium may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N05CE02, methyprylon, Methyprylon may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02CA04, methysergide, Methysergide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Doxacurium.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[P01AB01, metronidazole, The therapeutic efficacy of Doxacurium can be increased when used in combination with Metronidazole.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CA10, mezlocillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Mezlocillin.]
[N06AX03, mianserin, Mianserin may increase the anticholinergic activities of Doxacurium.]
[S02AA13, miconazole, The therapeutic efficacy of Doxacurium can be increased when used in combination with Miconazole.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Doxacurium.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AE02, molindone, Molindone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01BD01, amiodarone, Amiodarone may increase the neuromuscular blocking activities of Doxacurium.]
[N06AA09, amitriptyline, Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Morphine.]
[A04AA05, palonosetron, Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Doxacurium may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Doxacurium may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M03AC03, vecuronium, Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CA02, amobarbital, Amobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA17, amoxapine, Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Doxacurium can be decreased when used in combination with Fosphenytoin.]
[C07AA12, nadolol, Doxacurium may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Amoxicillin.]
[N04BC04, ropinirole, Doxacurium may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Nafcillin.]
[C04AX21, nafronyl, Naftidrofuryl may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Nalbuphine.]
[V03AB15, naloxone, Doxacurium may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Naltrexone.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AX21, duloxetine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Duloxetine.]
[N04BX01, tolcapone, Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S03AA01, neomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Neomycin.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Doxacurium is combined with Remifentanil.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01EB06, neostigmine, Neostigmine may increase the neuromuscular blocking activities of Doxacurium.]
[N05AX14, iloperidone, Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01AA19, ampicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Ampicillin.]
[L03AX16, plerixafor, Doxacurium may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Netilmicin.]
[N06AX23, desvenlafaxine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Desvenlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01CE01, inamrinone, Doxacurium may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA04, nicardipine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Nicardipine.]
[C08CA05, nifedipine, Nifedipine may increase the neuromuscular blocking activities of Doxacurium.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C08CA06, nimodipine, Nimodipine may increase the neuromuscular blocking activities of Doxacurium.]
[C08CA07, nisoldipine, Nisoldipine may increase the neuromuscular blocking activities of Doxacurium.]
[N05CD02, nitrazepam, Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08CA08, nitrendipine, Nitrendipine may increase the neuromuscular blocking activities of Doxacurium.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04BC05, pramipexole, Doxacurium may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AX04, nomifensine, Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06AA10, nortriptyline, Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[G02CA02, nylidrin, Nylidrin may increase the neuromuscular blocking activities of Doxacurium.]
[N06AA05, opipramol, Opipramol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Doxacurium is combined with Opium.]
[P01AB03, ornidazole, The therapeutic efficacy of Doxacurium can be increased when used in combination with Ornidazole.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01AC01, ouabain, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Ouabain.]
[J01CF04, oxacillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Oxacillin.]
[N05BA04, oxazepam, Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C07AA02, oxprenolol, Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Oxycodone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Doxacurium is combined with Oxymorphone.]
[N05AE01, oxypertine, Oxypertine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A03AB03, oxyphenonium, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[S01AA04, oxytetracycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Oxytetracycline.]
[N05AH05, asenapine, Asenapine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M03AC01, pancuronium, Pancuronium may increase the neuromuscular blocking activities of Doxacurium.]
[J04AB30, capreomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Capreomycin.]
[N05CC05, paraldehyde, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A07AA06, paromomycin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Paromomycin.]
[G04BD11, fesoterodine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Penbutolol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AG03, penfluridol, Penfluridol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S01AA14, penicillin G, The therapeutic efficacy of Doxacurium can be increased when used in combination with Benzylpenicillin.]
[J01CE09, penicillin G procaine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Procaine benzylpenicillin.]
[J01CE02, penicillin V, The therapeutic efficacy of Doxacurium can be increased when used in combination with Phenoxymethylpenicillin.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Pentazocine.]
[N05CA01, pentobarbital, Pentobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[L01XX08, pentostatin, Doxacurium may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AB10, perazine, Perazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04BC02, pergolide, Pergolide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C08EX02, perhexiline, Perhexiline may increase the neuromuscular blocking activities of Doxacurium.]
[N05AB03, perphenazine, Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AA02, phenobarbital, Phenobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Doxacurium.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Doxacurium is combined with Phenoperidine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N03AB02, phenytoin, The therapeutic efficacy of Doxacurium can be decreased when used in combination with Phenytoin.]
[S01AE05, levofloxacin, Doxacurium may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[V03AB19, physostigmine, Physostigmine may increase the neuromuscular blocking activities of Doxacurium.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C08CX01, mibefradil, Mibefradil may increase the neuromuscular blocking activities of Doxacurium.]
[N05AG02, pimozide, Pimozide may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C07AA03, pindolol, Pindolol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01CA12, piperacillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Piperacillin.]
[N05AC04, pipothiazine, Pipotiazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N06BX03, piracetam, Doxacurium may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[A02BX03, pirenzepine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Doxacurium is combined with Piritramide.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[J01CA02, pivampicillin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Pivampicillin.]
[N02CX01, pizotyline, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[N05CA22, proxibarbal, Proxibarbal may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Doxacurium.]
[A03AE01, alosetron, Alosetron may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Doxacurium which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH03, saxagliptin, Doxacurium may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, The risk or severity of gastrointestinal ulceration can be increased when Doxacurium is combined with Potassium chloride.]
[N05BA11, prazepam, Prazepam may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[S03BA02, prednisolone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Prednisone.]
[C01DX02, prenylamine, Prenylamine may increase the neuromuscular blocking activities of Doxacurium.]
[N01BB04, prilocaine, Prilocaine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AA03, primidone, Primidone may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01BA02, procainamide, The therapeutic efficacy of Doxacurium can be increased when used in combination with Procainamide.]
[S01HA05, procaine, Procaine may increase the neuromuscular blocking activities of Doxacurium.]
[L01XB01, procarbazine, Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N05AB04, prochlorperazine, Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N04AA04, procyclidine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[N05AA03, promazine, Promazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[R06AD02, promethazine, Promethazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01AX04, propanidid, Propanidid may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[A03AB05, propantheline, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, Periciazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CM06, propiomazine, Propiomazine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N01AX10, propofol, Propofol may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Doxacurium is combined with Dextropropoxyphene.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C01AB01, proscillaridin, The risk or severity of Cardiac Arrhythmia can be increased when Doxacurium is combined with Proscillaridin.]
[N02CC04, rizatriptan, Rizatriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[B01AC09, epoprostenol, Doxacurium may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N06AA11, protriptyline, Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05AX12, aripiprazole, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.]
[N07XX07, dalfampridine, Doxacurium may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[A03AB15, diphemanil, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Doxacurium may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, Talbutal may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CA09, vinbarbital, Vinbarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05BB02, captodiamine, Captodiame may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[M03BA04, styramate, Styramate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[P02CC01, pyrantel, Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N07AA02, pyridostigmine, Pyridostigmine may increase the neuromuscular blocking activities of Doxacurium.]
[R06AC01, pyrilamine, Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[C01BA01, quinidine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Quinidine.]
[P01BC01, quinine, The therapeutic efficacy of Doxacurium can be increased when used in combination with Quinine.]
[A02BA02, ranitidine, Ranitidine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[C02AA02, reserpine, Reserpine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[N06AX01, 5-hydroxytryptophan, Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01AA09, rolitetracycline, The therapeutic efficacy of Doxacurium can be increased when used in combination with Rolitetracycline.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[S01FA02, scopolamine, Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N05CA06, secobarbital, Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[V04CK01, secretin, The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Doxacurium.]
[N04BD01, selegiline, Selegiline may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[J01GB08, sisomicin, The therapeutic efficacy of Doxacurium can be increased when used in combination with Sisomicin.]
[A12CD01, sodium fluoride, Doxacurium may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Doxacurium.]
[C03DA01, spironolactone, Spironolactone may increase the neuromuscular blocking activities of Doxacurium.]
[N02BA03, choline salicylate, Doxacurium may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Doxacurium may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Doxacurium may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Doxacurium may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[V04CH02, indigo carmine, Doxacurium may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Chloral hydrate may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[N03AG01, valproic acid, Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Doxacurium.]
[D07AB02, hydrocortisone butyrate, The risk or severity of myopathy and weakness can be increased when Doxacurium is combined with Hydrocortisone butyrate.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Doxacurium which could result in a higher serum level.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Doxacurium is combined with Ipratropium.]
